Skip to content


Invest in the Future of Surgery

Our mission is to fundamentally change the nature of surgery and allow previously unimaginable surgical techniques in the most difficult-to-reach areas of the body. Join us to help bring the next generation of surgical technology to surgeons and patients around the world.

Investment Summary
Security Type
Class A Preferred Shares
7% paid-in-kind dividend
Success Bonus
Upon a change of control, shares are redeemed with a bonus multiple of:
• 100% after 1 year
• 200% after 3 years
• 300% after 5 years
Stock Price
$1.00 per share
Minimum Investment

We have applied to extend our Offering, and our extension of the Offering is being reviewed by the United States Securities and Exchange Commission. Until they approve our extension, we cannot accept additional investments. Unfortunately, we do not know how long the SEC’s process will take. If you have any questions or concerns, please email Mark Pickrell at We apologize for any inconvenience.

An offering statement regarding this offering has been filed with the SEC. The SEC has qualified the offering statement, which only means that the company may make sales of the securities described by the offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. Investors should read the offering circular before making any investment.

Securities offered through C2M Securities, LLC. member FINRA / SIPC. Disclaimer: private securities offerings may have a long holding period, be illiquid, and contain a high degree of risk. Investors must be able to afford the loss of all of their principal. BrokerCheck.